| High expression of the cysteine proteinase legumain in colorectal cancer–Implications for therapeutic targeting MH Haugen, K Boye, JM Nesland, SJ Pettersen, EV Egeland, T Tamhane, ... European journal of cancer 51 (1), 9-17, 2015 | 73 | 2015 |
| Generation and characterization of an immortalized human mesenchymal stromal cell line M Skårn, P Noordhuis, MY Wang, M Veuger, SH Kresse, EV Egeland, ... Stem cells and development 23 (19), 2377-2389, 2014 | 42 | 2014 |
| Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4 L Prasmickaite, EM Tenstad, S Pettersen, S Jabeen, EV Egeland, S Nord, ... Molecular oncology 12 (9), 1540-1558, 2018 | 37 | 2018 |
| Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer EV Egeland, K Boye, D Park, M Synnestvedt, T Sauer, B Naume, ... Breast cancer research and treatment 162, 127-137, 2017 | 29 | 2017 |
| Expression and clinical significance of Wee1 in colorectal cancer EV Egeland, K Flatmark, JM Nesland, VA Flørenes, GM Mælandsmo, ... Tumor Biology 37 (9), 12133-12140, 2016 | 18 | 2016 |
| Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes EV Egeland, K Boye, SJ Pettersen, MH Haugen, T Øyjord, L Malerød, ... Clinical & experimental metastasis 32, 755-767, 2015 | 13 | 2015 |
| Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment K Seip, K Jørgensen, MV Haselager, M Albrecht, MH Haugen, ... Cancer letters 439, 1-13, 2018 | 9 | 2018 |
| Oslo Breast Cancer C, Naume B, Borgen E, Maelandsmo GM: Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer EV Egeland, K Boye, D Park, M Synnestvedt, T Sauer Breast cancer research and treatment 162 (1), 127-137, 2017 | 5 | 2017 |
| Breast cancer patient-derived explant cultures recapitulate in vivo drug responses S Pettersen, GF Øy, EV Egeland, S Juell, O Engebråten, GM Mælandsmo, ... Frontiers in Oncology 13, 1040665, 2023 | 4 | 2023 |
| Liver X receptors induce antiproliferative effects in basal‐like breast cancer MH Haugen, H von der Lippe Gythfeldt, EV Egeland, L Svartdal Normann, ... Molecular Oncology 17 (10), 2041-2055, 2023 | 1 | 2023 |
| Legumain in colorectal cancer: Unorthodox localization and trafficking MH Haugen, K Flatmark, I Damgaard, T Tamhane, B Engesæter, S Tveito, ... Cancer Research 74 (19_Supplement), 1093-1093, 2014 | 1 | 2014 |
| From tumor progression to therapeutic control: Combinatorial targeting of immune vulnerabilities in TNBC A Poissonnier, EV Egeland, W Horton, S Sivagnanam, O Stapleton, ... Cancer Research 84 (6_Supplement), 4027-4027, 2024 | | 2024 |
| Breast cancer with different chemosensitivity has distinct influence on the immune microenvironment E Skourti, K Seip, EV Egeland, S Jabeen, N Mensali, I Øynebråten, S Juell, ... Cancer Research 84 (6_Supplement), 5554-5554, 2024 | | 2024 |
| Pre-treatment protein landscape in HER2-negative breast cancer treated with carboplatin in a neoadjuvant chemotherapy setting MA Dahle, EV Egeland, L Prasmickaite, OC Lingjærde, H Russnes, ... Cancer Research 83 (7_Supplement), 2170-2170, 2023 | | 2023 |
| Relieving immune suppressive pathways in breast cancer to improve outcomes A Poissonnier, EV Egeland, R Erbe, W Horton, A Howells-Ferreira, ... Cancer Research 83 (7_Supplement), 4164-4164, 2023 | | 2023 |
| Chemoresistant patient-derived xenografts to identify treatment options in breast cancer patients not responding to standard chemotherapy EV Egeland, K Seip, G Frode Øy, E Skourti, SJ Pettersen, S Juell, ... Cancer Research 83 (7_Supplement), 4675-4675, 2023 | | 2023 |
| Explainable Machine Learning Reveals the Role of the Breast Tumor Microenvironment in Neoadjuvant Chemotherapy Outcome Y Azimzade, M Haugen, X Tekpli, CB Steen, T Fleischer, D Kilburn, H Ma, ... bioRxiv, 2023.09. 07.556655, 2023 | | 2023 |
| Basal-like breast cancer engages tumor-supportive macrophages via cytokines triggered by extracellular S100A4 L Prasmickaite, EM Tenstad, EV Egeland, S Pettersen, S Jabeen, S Nord, ... Cancer Research 78 (13_Supplement), 114-114, 2018 | | 2018 |
| Basal-like breast cancer engages tumor-supportive macrophages via a cytokine network triggered by extracellular S100A4 EM Tenstad, L Prasmickaite, S Pettersen, EV Egeland, K Andersen, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 510-510, 2017 | | 2017 |
| Targetable nodes in fibroblast-supported melanoma cells that show resistance to BRAF inhibitors K Seip, MV Haselager, K Jørgensen, M Albrecht, MH Haugen, ... Cancer Research 77 (13_Supplement), 4329-4329, 2017 | | 2017 |
